Your browser doesn't support javascript.
loading
PROTOCOL FOR LIVER TRANSPLANTATION IN HILAR CHOLANGIOCARCINOMA.
Ernani, Lucas; Martino, Rodrigo Bronze de; Andraus, Wellington; Fernandes, Eduardo de Souza Martins; Mello, Felipe Pedreira Tavares de; Andrade, Ronaldo; Pimentel, Leandro Savattone; Haddad, Luciana Bertocco de Paiva; Coelho, Fabricio Ferreira; Herman, Paulo; D'Albuquerque, Luiz Augusto Carneiro.
  • Ernani L; Department of Gastroenterology, Hospital de Clínicas, Medical School, University of São Paulo, São Paulo, SP, Brazil.
  • Martino RB; Department of Gastroenterology, Hospital de Clínicas, Medical School, University of São Paulo, São Paulo, SP, Brazil.
  • Andraus W; Department of Gastroenterology, Hospital de Clínicas, Medical School, University of São Paulo, São Paulo, SP, Brazil.
  • Fernandes ESM; Department of General Surgery and Transplantation, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brazil.
  • Mello FPT; Abdominal Transplant Surgery, Hospital São Lucas - Copacabana, Rio de Janeiro, RJ, Brazil.
  • Andrade R; Department of General Surgery and Transplantation, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brazil.
  • Pimentel LS; Abdominal Transplant Surgery, Hospital São Lucas - Copacabana, Rio de Janeiro, RJ, Brazil.
  • Haddad LBP; Department of General Surgery and Transplantation, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brazil.
  • Coelho FF; Abdominal Transplant Surgery, Hospital São Lucas - Copacabana, Rio de Janeiro, RJ, Brazil.
  • Herman P; Department of General Surgery and Transplantation, Hospital Adventista Silvestre, Rio de Janeiro, RJ, Brazil.
  • D'Albuquerque LAC; Abdominal Transplant Surgery, Hospital São Lucas - Copacabana, Rio de Janeiro, RJ, Brazil.
Arq Bras Cir Dig ; 34(3): e1618, 2022.
Article en En, Pt | MEDLINE | ID: mdl-35019130
BACKGROUND: Hilar cholangiocarcinoma represents more than half of all cholangiocarcinoma cases, having poor prognosis and presenting a median overall survival after diagnosis of 12-24 months. In patients who have unresectable tumors with a better prognosis, the proposal to perform liver transplantation emerged for expanding the possibility of free margins by performing total hepatectomy. AIM: To provide a Brazilian protocol for liver transplantation in patients with hilar cholangiocarcinoma. METHOD: The protocol was carried out by two Brazilian institutions which perform a large volume of resections and liver transplantations, based on the study carried out at the Mayo Clinic. The elaboration of the protocol was conducted in four stages. RESULT: A protocol proposal for this disease is presented, which needs to be validated for clinical use. CONCLUSION: The development of a liver transplantation protocol for cholangiocarcinoma aims not only to standardize the treatment, but also enable a better assessment of the surgical results in the future.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Trasplante de Hígado / Tumor de Klatskin / Colangiocarcinoma Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En / Pt Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de los Conductos Biliares / Trasplante de Hígado / Tumor de Klatskin / Colangiocarcinoma Tipo de estudio: Guideline / Observational_studies Límite: Humans Idioma: En / Pt Año: 2022 Tipo del documento: Article